Ambee Pharmaceuticals PLC - Laporan Laba Rugi (TTM)

Ambee Pharmaceuticals PLC
BD ˙ DSE
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Ambee Pharmaceuticals PLC menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
Revenue 241 188 147 99 109 136 134 181 186 180 191 198 208 209 205 219 232 226 235
Change (%) -21.93 -22.08 -32.51 9.89 24.58 -1.06 35.00 2.83 -3.42 6.31 3.66 4.87 0.74 -1.93 6.85 5.88 -2.54 3.94
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 114 85 66 58 64 78 78 84 86 82 88 92 97 97 95 103 109 105 110
Change (%) -25.75 -21.99 -11.72 10.40 21.65 -0.72 7.64 2.65 -4.73 7.57 5.11 4.88 0.20 -1.75 7.93 5.84 -3.85 5.31
% of Revenue 47.26 44.95 45.00 58.87 59.14 57.75 57.95 46.20 46.12 45.50 46.03 46.68 46.68 46.43 46.52 46.99 46.97 46.34 46.95
Gross Operating Profit 127 104 81 41 44 57 56 97 100 98 103 106 111 112 110 116 123 121 125
Change (%) -18.51 -22.15 -49.53 9.16 28.84 -1.53 72.70 2.98 -2.29 5.25 2.43 4.86 1.21 -2.08 5.91 5.91 -1.38 2.76
% of Revenue 52.74 55.05 55.00 41.13 40.86 42.25 42.05 53.80 53.88 54.50 53.97 53.32 53.32 53.57 53.48 53.01 53.03 53.66 53.05
SG&A 118 96 74 48 52 65 64 83 85 82 87 92 98 99 97 104 111 109 112
Change (%) -18.17 -22.56 -35.57 8.67 25.39 -1.99 28.75 2.65 -2.93 6.16 5.93 5.97 1.42 -2.80 7.52 6.66 -1.61 2.48
% of Revenue 48.75 51.10 50.79 48.49 47.95 48.26 47.80 45.59 45.51 45.74 45.68 46.67 47.17 47.49 47.06 47.35 47.70 48.16 47.48
R&D
Change (%)
% of Revenue
OpEx 231 181 140 106 116 144 142 166 171 164 175 185 195 197 192 207 220 214 222
Change (%) -21.90 -22.29 -24.37 9.62 23.32 -1.30 17.18 2.65 -3.83 6.86 5.52 5.42 0.81 -2.28 7.72 6.26 -2.72 3.87
% of Revenue 96.01 96.05 95.79 107.36 107.09 106.01 105.75 91.79 91.63 91.24 91.71 93.35 93.85 93.92 93.58 94.34 94.68 94.50 94.43
Operating Income 10 7 6 -7 -8 -8 -8 15 16 16 16 13 13 13 13 12 12 12 13
Change (%) -22.72 -16.88 -217.97 5.96 5.50 -5.28 -292.69 4.82 1.16 0.55 -16.85 -2.98 -0.39 3.55 -5.84 -0.39 0.65 5.23
% of Revenue 3.99 3.95 4.21 -7.36 -7.09 -6.01 -5.75 8.21 8.37 8.76 8.29 6.65 6.15 6.08 6.42 5.66 5.32 5.50 5.57
Interest Expense -7 -6 -7 -5 -5 -4 -4 -5 -5 -4 -3 -2 -2 -1 -1 -1
Change (%) -0.43 2.45 -24.81 -5.82 -11.24 2.20 8.28 -2.06 -2.72 -26.43 -23.17 -25.55 -22.44 -40.07 -32.70
% of Revenue -2.70 -3.45 -4.53 -5.05 -4.33 -3.08 -3.18 -2.55 -2.43 -2.45 -1.70 -1.26 -0.89 -0.69 -0.42 -0.26
Net Income 2 1 -1 -13 -13 -13 -13 8 8 9 9 9 10 11 11 10 10 10 10
Change (%) -74.35 -191.21 2,434.66 0.86 -0.64 -1.84 -162.97 4.24 3.62 8.14 -3.44 9.47 5.80 1.45 -9.34 2.46 0.30 1.28
% of Revenue 0.91 0.30 -0.35 -13.14 -12.06 -9.62 -9.55 4.45 4.51 4.84 4.93 4.59 4.79 5.03 5.20 4.42 4.27 4.40 4.28

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista